Clinical Trials Browser

OTHER × Interventional × Atrasentan × Clear all

NCT00653328 2012-05-23

Ph II Atrasentan + DOXIL in Recurrent Ovarian/Fallopian/Peritoneal Serous Papillary Adenocarcinoma

Phase 2 Terminated

15 enrolled 10 charts

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00181558 2010-05-10

Atrasentan and Zometa for Men With Prostate Cancer Metastatic to Bone

Phase 2 Completed

Prostatic Neoplasms